Attempt to treat congenital pseudarthrosis of the tibia with mesenchymal stromal cell transplantation

References

• Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, . The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51–7.
   PubMed Web of Science ®Google Scholar
• Crawford AHJ, Bagamery N. Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop. 1986;6:72–88.
   PubMed Web of Science ®Google Scholar
• Lammert M, Kappler M, Mautner V, Lammert K, Störkel S, Friedman JM, . Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int. 2005;16:1161–6.
   PubMed Web of Science ®Google Scholar
• Andersen KS. Congenital pseudarthrosis of the tibia and neurofibromatosis. Acta Orthop Scand. 1976;47:108–11.
   PubMed Web of Science ®Google Scholar
• Paterson D. Congenital pseudarthrosis of the tibia. An overview. Clin Orthop Relat Res. 1989;247:44–54.
   Google Scholar
• Vitale MG, Guha A, Skaggs DL. Orthopaedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res. 2002;401:107–18.
   Google Scholar
• Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, . Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet. 1999;84:413–9.
   PubMed Web of Science ®Google Scholar
• Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D'Astous JL, . Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet. 2006;79:143–8.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Yoshida T, Yamamoto H, Oda Y, Tsuneyoshi M, Iwamoto Y. Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene. J Orthop Sci. 2007;12:361–5.
   PubMed Web of Science ®Google Scholar
• Anderson DJ, Schoenecker PL, Sheridan JJ, Rich MM. Use of an intramedullary rod for the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Am. 1992;74:161–8.
   PubMedGoogle Scholar
• Charnley J. Congenital pseudarthrosis of the tibia treated by intramedullary nail. J Bone Joint Surg Am. 1956;38A:283–90.
   Google Scholar
• Hagan KF, Buncke HJ. Treatment of congenital pseudarthrosis of the tibia with free vascularized bone graft. Clin Orthop Relat Res. 1982;166:34–44.
   Google Scholar
• Weiland AJ, Weiss AP, Moore JR, Tolo VT. Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Am. 1990;72:654–62.
   PubMed Web of Science ®Google Scholar
• Paley D, Catagni M, Argnani F, Prevot J, Bell D, Armstrong P. Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop Relat Res. 1992;280:81–93.
   Google Scholar
• McCarthy RE. Amputation for congenital pseudarthrosis of the tibia. Indications and techniques. Clin Orthop Relat Res. 1982;166:58–61.
   Google Scholar
• Ito H, Shirai Y, Gembun Y. A case of congenital pseudarthrosis of the tibia treated with pulsing electromagnetic fields. 17-year follow-up. J Nippon Med Sch. 2000;67:198–201.
   PubMedGoogle Scholar
• Okada K, Miyakoshi N, Takahashi S, Ishigaki S, Nishida J, Itoi E. Congenital pseudoarthrosis of the tibia treated with low-intensity pulsed ultrasound stimulation (LIPUS). Ultrasound Med Biol. 2003;29:1061–4.
   PubMed Web of Science ®Google Scholar
• Garg NK, Gaur S. Percutaneous autogenous bone-marrow grafting in congenital tibial pseudarthrosis. J Bone Joint Surg Br. 1995;77:830–1.
   PubMedGoogle Scholar
• Fabeck L, Ghafil D, Gerroudj M, Baillon R, Delincé P. Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Br. 2006;88:116–8.
   PubMedGoogle Scholar
• Long MW, Robinson JA, Ashcraft EA, Mann KG. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest. 1995;95:881–7.
   PubMed Web of Science ®Google Scholar
• Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science. 1983;220:680–6.
   PubMed Web of Science ®Google Scholar
• Sammons J, Ahmed N, El-Sheemy M, Hassan HT. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev. 2004;13:273–80.
   PubMed Web of Science ®Google Scholar
• Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, . The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108:17–29.
   PubMed Web of Science ®Google Scholar
• Long MW. Osteogenesis and bone-marrow-derived cells. Blood Cells Mol Dis. 2001;27:677–90.
   PubMed Web of Science ®Google Scholar
• Hong J, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, . TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309:1074–8.
   PubMed Web of Science ®Google Scholar
• Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994;134:277–86.
   PubMed Web of Science ®Google Scholar
• Leskelä H, Risteli J, Niskanen S, Koivunen J, Ivaska KK, Lehenkari P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun. 2003;311:1008–13.
   PubMed Web of Science ®Google Scholar
• Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res. 1998;16:155–62.
   PubMed Web of Science ®Google Scholar
• Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, Katoh M, . Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis: a preliminary result of three cases. Bone. 2004;35:892–8.
   PubMed Web of Science ®Google Scholar
• Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone. 2007;40:522–8.
   PubMed Web of Science ®Google Scholar
• Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, Quarto R, . Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng. 2007;13:947–55.
   PubMedGoogle Scholar
• Vacanti CA, Bonassar LJ, Vacanti MP, Shufflebarger J. Replacement of an avulsed phalanx with tissue-engineered bone. N Engl J Med. 2001;344:1511–4.
   PubMed Web of Science ®Google Scholar
• Leskelä H, Kuorilehto T, Risteli J, Koivunen J, Nissinen M, Peltonen S, . Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. Bone. 2009;44:243–50.
   PubMed Web of Science ®Google Scholar
• Wang X, Li F, Niyibizi C. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Stem Cells. 2006;24:1869–78.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Poignard A, Beaujean F, Rouard H. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am. 2005;87:1430–7.
   PubMed Web of Science ®Google Scholar
• Lazennec G, Jorgensen C. Concise review. Adult multipotent stromal cells and cancer: risk or benefit? Stem Cells. 2008;26:1387–94.
   PubMed Web of Science ®Google Scholar
• Adachi N, Ochi M, Deie M, Ito Y. Transplant of mesenchymal stem cells and hydroxyapatite ceramics to treat severe osteochondral damage after septic arthritis of the knee. J Rheumatol. 2005;32:1615–8.
   PubMed Web of Science ®Google Scholar
• Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213:341–7.
   PubMed Web of Science ®Google Scholar
• Mishra PK. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation? J Cardiovasc Med (Hagerstown). 2008;9:122–8.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.
   Google Scholar
• Bielby R, Jones E, McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury. 2007;38(Suppl 1):S26–32.
   Google Scholar
• Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg Am. 2004;86A:1186–97.
   Web of Science ®Google Scholar
• Heikkinen ES, Poyhonen MH, Kinnunen PK, Seppänen UI. Congenital pseudarthrosis of the tibia. Treatment and outcome at skeletal maturity in 10 children. Acta Orthop Scand. 1999;70:275–82.
   PubMed Web of Science ®Google Scholar
• Johnston CE2. Congenital pseudarthrosis of the tibia: results of technical variations in the Charnley–Williams procedure. J Bone Joint Surg Am. 2002;84A:1799–810.
   Web of Science ®Google Scholar
• Ohnishi I, Sato W, Matsuyama J, Yajima H, Haga N, Kamegaya M, . Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan. J Pediatr Orthop. 2005;25:219–24.
   PubMed Web of Science ®Google Scholar